It’s a sad fact of life that war is good for business. Companies that manufacture weapons need to prove their technology works. So small wars are excellent testing grounds for both the current and new ideas. If everything performs as it should, other governments around the world will buy the systems for their own armed forces. But wars are not just about the latest guns, armored vehicles, ships or airplanes. They also test the people who fight. Despite the drive to keep fighters safe by using drones and other systems to kill the enemy from a safe distance, human beings still have to go face-to-face with the enemy in combat. Once you put people into real fighting situations, they get injured. For a while, this was not a problem but, as the engagement in both Iraq and Afghanistan has continued, the strain on the volunteer forces has increased. Military personnel are being rotated more rapidly with less time to recover from injury. As this is being written, President Obama is considering whether to increase the contribution to the NATO force in Afghanistan. If an increase is authorized, this will put even more strain on the armed services.
The US Government Accountability Office is responsible for monitoring how effectively the Department of Defense uses its resources. Deployment strategies have seen more rapid rotations of soldiers into combat zones for longer tours of duty. This has led to an increasing chorus of complaints that there are not enough uninjured personnel to form an effective fighting force. In recent studies, some 15% of the enlisted personnel “resting” in the US were injured. These were not life-threatening conditions. The people were “walking wounded”. But, when their time came to return to the combat zone, almost three-quarters were sent back even though still injured. Unfortunately, it’s not for the GAO to review how commanders in the field use injured personnel. All that can be said is that all serve their country with honor.
Despite the efforts of the Department of Defense to reduce blogging by serving personnel, there has been a steady stream of evidence about the use of tramadol. Back home, families also give interviews in their local newspapers confirming they routinely end bottles of tramadol out to their family members. All this anecdotal evidence confirms the power of this drug to keep people mobile and active, even in a high-stress environment. Leaving aside the question of whether US personnel should be fighting overseas, the reality is that the freedom of the families to buy tramadol online is helping to keep soldiers at their fighting best. Because their pain is relieved, they sleep better and fight with greater distinction. Cheap tramadol may be old technology but, in these two wars, it’s proving once again how effective it is to keep pain under control. So, if you also suffer from moderate to severe pain, you too can benefit from the use of tramadol – the most commonly used drug in combat zones is available to help you fight the pain on the home front. Get a better quality of life and buy tramadol online today.
One of the most common causes of erectile dysfunction is performance anxiety. Put simply, as men age, they begin to lose confidence that the erections of their youth will continue. It only takes one or two failures to get an erection hard enough for penetration and the worry starts to build. Soon, the worry becomes a self-fulfilling prophesy. The anxiety takes over and erections fade away.
If you asked men to identify all their phobias, fear of sexual failure would obviously be high on the list. So much male self-esteem is wrapped up in the ability to be successful in the bedroom. But there’s also a widespread fear of spiders. Rightly or wrongly, many men find the presence of a spider disconcerting if not actually frightening. This despite the fact that, in the northern hemisphere, almost all the varieties of spiders are completely harmless. It seems to have something to do with the number of legs and the speed of the creatures.
This is the time to start talking about Brazil. Not only has it hit the headlines because Rio has been selected as the venue for the Olympics in 2016, it’s also the home of Phoneutria nigriventer, better known as the wandering spider. For those of you who like statistics, this is one of the most venomous spiders in the world and it’s responsible for the deaths of many. However, there’s a very good reason for overcoming your fear of this spider. When it sinks its fangs dripping with venom into a man, it not only puts the victim on the road to possible death unless treated, it also causes a long-lasting erection. In theory, this could make it a very pleasurable way to die except the erection apparently grows painful over time.
Attracted by news of this spider, US scientists have been injecting the venom into rats. There’s now clear clinical evidence that an active component of the venom relaxes blood vessels. This makes it a potential life-saving drug to reduce high blood pressure and, as a side effect, also treat erectile dysfunction. Pharmaceutical companies are therefore lining up to investigate this venom. The reason for the interest is that it’s a completely different chemical from levitra and the other drugs currently used to treat erectile dysfunction. The idea of developing a completely different class of drugs from a natural source makes this a very attractive commercial venture.
Until the development work is completed and FDA approval won, men will just have to struggle on with levitra. After all, it only produces six hours of sexual responsiveness from the “as needed” version taken by men with a wide range of different physical and psychological problems. In other words, levitra effectively has the erectile dysfunction market sewn up and it will take something phenomenal from the spider to beat it. But the potential applications to treat diseases of blood vessels, high blood pressure and heart disease may make the spiders the overall winners. It is possible that overcoming the fear of spiders may really pay health and stock dividends in the long run.
Recent Comments